Announcements Trials
Browse Landscape

Phase

Phase 2 68Phase 1 54Phase 1/2 47Phase 3 17Phase NA 5Phase EARLY_PHASE1 3Phase 2/3 3Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thymoma 1Pancreatic Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Large Cell 1Carcinoma 1Advanced Gastric Cancer 1Adenocarcinoma Pancreas 1Adenocarcinoma 1

Interventions

Gemcitabine 3Ethanol 3fish oil triglycerides 2S 1 (combination) 2Metronidazole 2Long-Term Synaptic Depression 2Dexamethasone 2pembrolizumab 1pasireotide 1nimotuzumab 1ferumoxtran-10 1alanylglutamine 1Tobacco Use Cessation Devices 1TachoSil 1Sunitinib 1Psychiatric Rehabilitation 1Pregabalin 1Polymerase Chain Reaction 1Polygeline 1Parenteral Nutrition 1Pancrelipase 1Oxaliplatin 1Nutritional Status 1Needles 1Mirtazapine 1Midazolam 1Meperidine 1Immunonutrition Diet 1Hydrocortisone 1Glucocorticoids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pancreatic Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT03401827 2018-02-12

The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

Seoul National University Hospital

Phase 4 Unknown
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡